Skip to content

Cannabidiol tempers alcohol intake and neuroendocrine and behavioural correlates in alcohol binge drinking adolescent rats. Focus on calcitonin gene‐related peptide's brain levels

Giuseppe Tringali, Gianluca Lavanco, Valentina Castelli, Giuseppe Pizzolanti, Martin Kuchař, Diego Currò, Carla Cannizzaro, Anna Brancato

Phytotherapy Research July 31, 2023 DOI: 10.1002/ptr.7972 via OpenAlex

Summary

AI-generated from the abstract

Adolescent rats that binge drink alcohol show reduced levels of the neuropeptide CGRP in brain regions involved in emotion and reward (medial prefrontal cortex, nucleus accumbens, amygdala) and increased CGRP in the brainstem. These rats also display heightened responses to rewarding and painful stimuli, reduced social drive, and lower corticosterone levels. Treatment with cannabidiol (40 mg/kg) before each drinking session reduced alcohol consumption and preference, normalized CGRP expression in corticolimbic areas, and corrected the abnormal reward and aversion responses as well as glucocorticoid levels. CGRP may mediate and be a target of alcohol binge drinking, and cannabidiol shows promise for limiting adolescent binge drinking and its behavioral and neuroendocrine consequences.

Study at a glance

Characteristics Animal study Peer reviewed
Population Adolescent male rats
Intervention Cannabidiol
Dose 40 mg/kg
Topics Cannabis CBD
Keywords Binge drinking Calcitonin gene-related peptide Endocrinology Internal medicine
Citations 17
Key finding Adolescent alcohol binge drinking alters CGRP expression in affect-related brain regions and induces behavioral and neuroendocrine abnormalities that can be partially reversed by cannabidiol treatment.

Abstract

Alcohol binge drinking is common among adolescents and may challenge the signalling systems that process affective stimuli, including calcitonin gene-related peptide (CGRP) signalling. Here, we employed a rat model of adolescent binge drinking to evaluate reward-, social- and aversion-related behaviour, glucocorticoid output and CGRP levels in affect-related brain regions. As a potential rescue, the effect of the phytocannabinoid cannabidiol was explored. Adolescent male rats underwent the intermittent 20% alcohol two-bottle choice paradigm; at the binge day (BD) and the 24 h withdrawal day (WD), we assessed CGRP expression in medial prefrontal cortex (mPFC), nucleus accumbens (NAc), amygdala, hypothalamus and brainstem; in addition, we evaluated sucrose preference, social motivation and drive, nociceptive response, and serum corticosterone levels. Cannabidiol (40 mg/kg, i.p.) was administered before each drinking session, and its effect was measured on the above-mentioned readouts. At BD and WD, rats displayed decreased CGRP expression in mPFC, NAc and amygdala; increased CGRP levels in the brainstem; increased response to rewarding- and nociceptive stimuli and decreased social drive; reduced serum corticosterone levels. Cannabidiol reduced alcohol consumption and preference; normalised the abnormal corticolimbic CGRP expression, and the reward and aversion-related hyper-responsivity, as well as glucocorticoid levels in alcohol binge-like drinking rats. Overall, CGRP can represent both a mediator and a target of alcohol binge-like drinking and provides a further piece in the intricate puzzle of alcohol-induced behavioural and neuroendocrine sequelae. CBD shows promising effects in limiting adolescent alcohol binge drinking and rebalancing the bio-behavioural abnormalities.

Explore topics

Comments

No comments yet.

Log in to comment